Society of Hospital Medicine Applauds Passage of Legislation Halting 5 Percent Cut in Medicare Payments to Physicians
Posted on: Wednesday, 20 December 2006, 15:00 CST
PHILADELPHIA, Dec. 20 /PRNewswire/ -- Laurence D. Wellikson, M.D., CEO of the Society of Hospital Medicine, issues the following statement in response to recent Congressional approval of legislation halting a 5 percent cut in Medicare payments to physicians:
"The passage of this legislation is important news for hospital medicine and our patients. This will allow hospitalists to continue to provide excellent care to the significant percentage of the Medicare population that we treat. With the start of the new congress in January, SHM will be aggressively working to educate Members of Congress on the vital importance of hospital medicine, the fastest-growing specialty in modern healthcare, and working to see these gains sustained for future years." About the Society of Hospital Medicine
The Society of Hospital Medicine was established in 1997 to support and enhance the practice of hospital medicine. Today it is the leading resource for hospitalists throughout the U.S. and Canada, with more than 6,000 members. SHM will mark its ten-year anniversary beginning in January 2007 and continuing throughout the year. For more information about hospitalists or the Society of Hospital Medicine, visit http://www.hospitalmedicine.org/.
Society of Hospital Medicine
CONTACT: Heather Palm of Society of Hospital Medicine, +1-215-351-2479,hpalm@hospitalmedicine.org
Web site: http://www.hospitalmedicine.org/
Source: PRNewswire
Related Articles
- A 50% Increase in Medical Bankruptcies - A Worry for Adults Assisting Aging Parents
- ASPETAR - Qatar Orthopaedic and Sports Medicine Hospital Named FIFA Medical Centre of Excellence
- American College of Physicians Issues Guideline for Drug Treatment of Men and Women With Osteoporosis or Low Bone Density
- U.S. Clinicians Indicate a Strong Need for New Tools to Combat Sepsis
- Generex Biotechnology Presented Data At The Endocrine Society's Annual Meeting
- Theratechnologies Announces Publication of Its 26-Week Phase 3 Data With Tesamorelin in the New England Journal of Medicine
- Hospitalists Linked to Earlier Discharge
- TeamHealth Expands Hospital Medicine Division Through Acquisition of Florida Acute Care Specialists
- Generex Biotechnology Makes Poster Presentations of Clinical Data at Endo 2006
- Society of Hospital Medicine Appoints Mark Williams, M.D., FACP, Editor-In-Chief of New Medical Journal
 |
 |
User Comments (0)
RSS Feeds